First in Human Study of QLS5316 in Solid Tumors

NCT07358884 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

300

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumors
Colorectal Cancer
Gastric Cancer or Gastroesophageal Junction Adenocarcinoma
Head and Neck Squamous Cell Carcinoma
Non-small Cell Lung Cancer

Interventions

DRUG: QLS5316

Sponsor

Qilu Pharmaceutical Co., Ltd.